| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $14.97M | $802.00K | $44.70M | $268.00K |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $71.06M | $84.11M | $84.72M | $48.74M | $45.49M |
| R&D | $25.56M | $42.24M | $44.87M | $42.35M | $20.37M |
| SG&A | $40.83M | $29.67M | $39.84M | $6.39M | $25.12M |
| Operating Income | -$70.56M | -$67.97M | -$83.91M | -$4.04M | -$45.22M |
| Interest Expense | – | – | $28.00K | $19.00K | $2.67M |
| Tax Expense | -$175.00K | -$44.00K | -$3.08M | -$4.47M | -$28.00K |
| Net Income | -$66.43M | -$61.07M | -$73.35M | $5.34M | -$50.87M |
| EPS (basic) | -1.6400 | -1.5500 | -1.9100 | 0.1400 | -1.9600 |
| EPS (diluted) | -1.6400 | -1.5500 | -1.9100 | 0.1400 | -1.9600 |
| Shares (diluted) | $40.53M | $39.35M | $38.39M | $38.17M | $25.89M |